Mindray's BeneVision N-Series is the first patient monitoring platform to integrate Edwards' FloTrac™ sensor technology to offer greater insights into advanced hemodynamic monitoring to manage ...
BRUSSELS, Belgium, March 22 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), a global leader in hemodynamic monitoring technologies, announced the European launch of its Edwards FloTrac(TM ...
Jan. 31, 2006 -- A dual-chamber implantable cardioverter defibrillator has been released on the European market following approval by the European Commission (EC) last year; the EC has approved an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback